Morgan Stanley »

Adicet Bio Ord shares owned by Morgan Stanley

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2026-03-31 $24k 3.5k 6.81
2025-12-31 $26k 3.0k 8.42

More positions owned by Morgan Stanley

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)

View all positions for Morgan Stanley

Top funds holding Adicet Bio Ord

RA Capital Management
OrbiMed Advisors
Franklin Resources
Citadel Advisors
Vanguard Capital Management
Woodline Partners
Vanguard Group
Adage Capital Partners GP
Prosight Management
Renaissance Technologies
Stonepine Capital Management
Alyeska Investment Group
Carlyle
Acadian Asset Management
Geode Capital Management

View all funds holding Adicet Bio Ord